APA (7th ed.) Citation

Yamamoto, K., Hokimoto, S., Chitose, T., Morita, K., Ono, T., Kaikita, K., . . . Ogawa, H. (2011). Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy. Journal of cardiology, 57(2), 194-201. https://doi.org/10.1016/j.jjcc.2010.10.007

Chicago Style (17th ed.) Citation

Yamamoto, Koichiro, et al. "Impact of CYP2C19 Polymorphism on Residual Platelet Reactivity in Patients with Coronary Heart Disease During Antiplatelet Therapy." Journal of Cardiology 57, no. 2 (2011): 194-201. https://doi.org/10.1016/j.jjcc.2010.10.007.

MLA (9th ed.) Citation

Yamamoto, Koichiro, et al. "Impact of CYP2C19 Polymorphism on Residual Platelet Reactivity in Patients with Coronary Heart Disease During Antiplatelet Therapy." Journal of Cardiology, vol. 57, no. 2, 2011, pp. 194-201, https://doi.org/10.1016/j.jjcc.2010.10.007.